Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MEF2B: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Comprehensive gene page for MEF2B (Myocyte Enhancer Factor 2B), a transcription factor involved in neuronal development, synaptic plasticity, and neurodegenerative disease mechanisms
No AI portrait yet
| Gene Symbol | MEF2B |
| Full Name | MEF2B (Myocyte Enhancer Factor 2B) |
| Aliases | Myocyte Enhancer Factor 2B |
| Chromosome | 19p13.11 |
| Protein Type | Gene |
| Function | encodes a transcription factor belonging to the MADS (MEF2, Agamous, Deficiens, serum response factor) box family of DNA-binding proteins. |
| Primary Expression | multiple tissues including adrenal, heart, intestine, kidney, lung, and stomach, reflecting its role in developmental transcriptional programs |
| Amino Acids | 365 aa |
| GeneCards | MEF2B |
| Human Protein Atlas | MEF2B |
| Dimerization | MEF2 proteins form homodimers and heterodimers with other MEF2 family members, expanding their combinatorial diversity |
| DNA binding | The MADS domain directly contacts the major groove of DNA at MEF2 response elements |
| Cofactor recruitment | The domain interacts with various transcriptional coactivators and corepressors, including HDACs |
| Highest expression | Lymphoid tissues including lymph node (RPKM 18.6) and appendix (RPKM 7.2) |
| Moderate expression | Adrenal gland, small intestine, lung, stomach, kidney, and heart |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
MEF2B["MEF2B"]
neurodegeneration["neurodegeneration"]
MEF2B -->|"implicated_in"| neurodegeneration
style MEF2B fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning MEF2B in their description or question text
No additional research found